(Q35751834)

10 August 2017

1 reference

title

Functional brain imaging in the differential diagnosis of Parkinson's disease (English)

1 reference

10 August 2017

1 reference

functional brain imaging

1 reference

Alan Whone

2

1 reference

ORCID Public Data File 2021

Paola Piccini

series ordinal

1

object named as

Paola Piccini

1 reference

10 August 2017

language of work or name

1 reference

1 May 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

3

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

284-290

1 reference

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Parkinson's disease. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Parkinson's disease. Second of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Parkinsonism-plus syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Vascular parkinsonism: a review of the precision and frequency of the diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Clinical Lewy body syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Accuracy of diagnosis in patients with presumed Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Issues in the early diagnosis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Prevalence of parkinsonian signs and associated mortality in a community population of older people.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Parkinsonian syndromes and differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Striatonigral degeneration. A clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Dopamine visualized in the basal ganglia of living man.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Plasticity of the nigropallidal pathway in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Clinical and [18F] dopa PET findings in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

A Two-Compartment Description and Kinetic Procedure for Measuring Regional Cerebral [11C]Nomifensine Uptake Using Positron Emission Tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

PET imaging of neocortical monoaminergic terminals in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

[11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

The metabolic topography of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Correlation of intellectual impairment in Parkinson's disease with FDG PET scan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Occipital glucose metabolism in dementia with lewy bodies with and without Parkinsonism: a study using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Dopamine transporter: Basic aspects and neuroimaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Slowing Parkinson's disease progression: recent dopamine agonist trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective co

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900736-7

7 January 2021

10.1016/S1474-4422(04)00736-7

Identifiers

DOI

1 reference

10 August 2017

1 reference